Effect of Formaldehyde Inactivation on Poliovirus
Open Access
- 15 October 2014
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 88 (20), 11955-11964
- https://doi.org/10.1128/jvi.01809-14
Abstract
Inactivated polio vaccines, which have been used in many countries for more than 50 years, are produced by treating live poliovirus (PV) with formaldehyde. However, the molecular mechanisms underlying virus inactivation are not well understood. Infection by PV is initiated by virus binding to specific cell receptors, which results in viral particles undergoing sequential conformational changes that generate altered structural forms (135S and 80S particles) and leads to virus cell entry. We have analyzed the ability of inactivated PV to bind to the human poliovirus receptor (hPVR) using various techniques such as ultracentrifugation, fluorescence-activated cell sorting flow cytometry and real-time reverse transcription-PCR (RT-PCR). The results showed that although retaining the ability to bind to hPVR, inactivated PV bound less efficiently in comparison to live PV. We also found that inactivated PV showed resistance to structural conversion in vitro , as judged by measuring changes in antigenicity, the ability to bind to hPVR, and viral RNA release at high temperature. Furthermore, viral RNA from inactivated PV was shown to be modified, since cDNA yields obtained by RT-PCR amplification were severely reduced and no infectious virus was recovered after RNA transfection into susceptible cells. IMPORTANCE This study represents a novel insight into the molecular mechanisms responsible for poliovirus inactivation. We show that inactivation with formaldehyde has an effect on early steps of viral replication as it reduces the ability of PV to bind to hPVR, decreases the sensitivity of PV to convert to 135S particles, and abolishes the infectivity of its viral RNA. These changes are likely responsible for the loss of infectivity shown by PV following inactivation. Techniques used in this study represent new approaches for the characterization of inactivated PV products and could be useful in developing improved methods for the production and quality control testing of inactivated polio vaccines. Measuring the antigenicity, capsid stability, and RNA integrity of inactivated PV samples could help establishing the optimal balance between the loss of infectivity and the preservation of virus antigenicity during inactivation.Keywords
This publication has 59 references indexed in Scilit:
- Poliovirus RNA Is Released from the Capsid near a Twofold Symmetry AxisJournal of Virology, 2011
- Catching a Virus in the Act of RNA Release: a Novel Poliovirus Uncoating Intermediate Characterized by Cryo-Electron MicroscopyJournal of Virology, 2010
- PicornavirusesCurrent Topics in Microbiology and Immunology, 2010
- A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCRVirology Journal, 2009
- The Risks, Costs, and Benefits of Possible Future Global Policies for Managing PoliovirusesAmerican Journal of Public Health, 2008
- Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNAJournal of Virological Methods, 2007
- Reduction of the Rate of Poliovirus Protein Synthesis through Large-Scale Codon Deoptimization Causes Attenuation of Viral Virulence by Lowering Specific InfectivityJournal of Virology, 2006
- Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA methodBiologicals, 2005
- Poliomyelitis eradicationVirus Research, 1999
- Potency of Wild-type or Sabin Trivalent Inactivated Poliovirus Vaccine, by Enzyme-Linked Immunosorbent Assay using Monoclonal Antibiotics Specific for Each Antigenic SiteBiologicals, 1997